Pharmabiz

Researchers develop high-resolution molecular maps of Alzheimer’s and related brain disorders

Researchers develop high-resolution molecular maps of Alzheimer’s and related brain disorders: Bethesda, Maryland Saturday, September 26, 2026, 16:00 Hrs [IST] A major research ...
Pharmabiz

Gossamer Bio files NDA with US FDA for seralutinib to treat pulmonary arterial hypertension

Gossamer Bio files NDA with US FDA for seralutinib to treat pulmonary arterial hypertension: San Diego Saturday, September 26, 2026, 15:00 Hrs [IST] Gossamer Bio Inc, a clinical-s ...
Pharmabiz

Recipharm inks manufacturing collaboration with CanVirex to advance oncolytic virus therapy

Recipharm inks manufacturing collaboration with CanVirex to advance oncolytic virus therapy: Switzerland Saturday, September 26, 2026, 14:00 Hrs [IST] Recipharm, a leading global ...
Pharmabiz

Molecular profiling is changing cancer treatment in India: Dr Raman Narang

Molecular profiling is changing cancer treatment in India. It helps in examining specific biomarkers, genes and other ...
Pharmabiz

Elevar Therapeutics’ lirafugratinib gets US FDA nod for treatment option for cholangiocarcinoma with FGFR2 fusion

Elevar Therapeutics’ lirafugratinib gets US FDA nod for treatment option for cholangiocarcinoma with FGFR2 fusion: Fort Lee, New Jersey Saturday, September 26, 2026, 13:00 Hrs [ ...
Pharmabiz

Heart valve procedure - different risks for women and men, says study

Heart valve procedure - different risks for women and men, says study: Krems, Austria Saturday, September 26, 2026, 12:00 Hrs [IST] Karl Landsteiner University, an internationally ...
Pharmabiz

Amneal Pharma receives US FDA approval for lanreotide injection

Amneal Pharma receives US FDA approval for lanreotide injection: Our Bureau, Mumbai Amneal Pharmaceuticals, Inc. announced that the U ...
Pharmabiz

US FDA accepts and grants priority review status to AstraZeneca’s sBLA for Imfinzi plus neoadjuvant enfortumab vedotin to treat patients with muscle-invasive bladder cancer

US FDA accepts and grants priority review status to AstraZeneca’s sBLA for Imfinzi plus neoadjuvant enfortumab vedotin to treat patients with muscle-invasive bladder cancer: Cam ...
Pharmabiz

Anton Paar India announces NEXUS to connect scientific insight on October 7–8, 2026, Navi Mumbai

Anton Paar India announces NEXUS to connect scientific insight on October 7–8, 2026, Navi Mumbai: Our Bureau, Mumbai Saturday, September 26, 2026, 10:00 Hrs [IST] Anton Paar Ind ...
Pharmabiz

NIHR to fund major partnerships to tackle the nation's biggest health and care challenges

NIHR to fund major partnerships to tackle the nation's biggest health and care challenges: United Kingdom Saturday, September 26, 2026, 10:15 Hrs [IST] The National Institute for ...
Pharmabiz

Novotech to acquire Adelaide-based specialist bioanalytical laboratory, Agilex Biolabs

Novotech to acquire Adelaide-based specialist bioanalytical laboratory, Agilex Biolabs: Singapore Saturday, September 26, 2026, 09:00 Hrs [IST] Novotech, the global full-service c ...
Pharmabiz

DTAB revises recommendation on exemption for requirement of wholesale license for liquid antiseptic in Schedule K

DTAB revises recommendation on exemption for requirement of wholesale license for liquid antiseptic in Schedule K: Gireesh Babu, New Delhi Saturday, September 26, 2026, 08:00 Hrs ...